---
title: "一篇顶一万篇 | 结直肠癌Bulk差异、单细胞、空转、Bulk生存数据集"
date: 2025-12-23T09:27:24Z
draft: ["false"]
tags: [
  "fetched",
  "医学僧的科研日记"
]
categories: ["Acdemic"]
---
一篇顶一万篇 | 结直肠癌Bulk差异、单细胞、空转、Bulk生存数据集 by 医学僧的科研日记
------
<div><section><span data-pm-slice="0 0 []"><strong><span leaf="">"一篇顶一万篇"栏目</span></strong><span leaf="">，书写经典、历久弥新的推文。</span></span></section><section data-role="uecloud-body" data-usign="30562" data-pm-slice="7 2 []"><section data-role="uecloud-body-main"><section data-role="uecloud" data-role-node="paragraph"><section><section><section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_gif/I1fyHmvzZiaX5oD1Bgk6NMQDadCzSN1MZPibIKOuzicZgtL1o4j2EYF97qyelWVde2giaMnHAibJibfBKrJicMKMiciawhw/640?from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp&amp;wx_fmt=gif#imgIndex=0" alt="图片" data-ratio="1" data-w="512" data-imgfileid="100028843" src="https://mmbiz.qpic.cn/sz_mmbiz_gif/I1fyHmvzZiaX5oD1Bgk6NMQDadCzSN1MZPibIKOuzicZgtL1o4j2EYF97qyelWVde2giaMnHAibJibfBKrJicMKMiciawhw/640?from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp&amp;wx_fmt=gif#imgIndex=0"></section><section><section><span leaf=""><br></span></section><section><section data-role-type="paragraph"><section data-role-type="text"><p><strong><strong><span data-pm-slice="0 0 []"><span leaf="">汇聚同道、前沿探索</span></span></strong><span data-pm-slice="0 0 []"><span leaf=""><br></span></span></strong></p><p><strong><strong><span leaf=""><br></span></strong></strong></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8chxL9kibK9iac0PZKrzCQa6212icOQETyGLUdE5uxBcH6xiatOkk85TkUa6mEGBlkW9p8TTYMiaPKDoIA/640?wx_fmt=other&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1#imgIndex=1" alt="图片" data-ratio="0.9314814814814815" data-s="300,640" data-type="jpeg" data-w="1080" type="block" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8chxL9kibK9iac0PZKrzCQa62LicPCtOpOqKSCkmLCb7vZzUGwcjg45aGF0Ig8XgiaWHiaQfThDlaJaY6Q/0?wx_fmt=jpeg&amp;from=appmsg" data-cropx2="1280" data-cropy1="454.1935483870967" data-cropy2="1644.7311827956987" data-imgfileid="100028842" src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8chxL9kibK9iac0PZKrzCQa6212icOQETyGLUdE5uxBcH6xiatOkk85TkUa6mEGBlkW9p8TTYMiaPKDoIA/640?wx_fmt=other&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1#imgIndex=1"></section><p><strong><span leaf=""><span textstyle="">科研交流群</span></span></strong></p><p><strong><span leaf=""><span textstyle="">请扫描上方二维码</span></span></strong></p></section></section></section></section></section></section></section></section></section></section><p data-pm-slice="0 0 []"><span leaf=""><br></span></p><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8fWoUoqkWdPb9NfKFb3FkJaojTiaPOxZTT4smnhHHAKTxd0O4oOM4TMZewT5ddZK9iaia9ibXwMLQFKIg/640?wx_fmt=jpeg&amp;from=appmsg" data-ratio="0.7462962962962963" data-s="300,640" data-type="png" data-w="1080" type="block" data-imgfileid="100028847" src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8fWoUoqkWdPb9NfKFb3FkJaojTiaPOxZTT4smnhHHAKTxd0O4oOM4TMZewT5ddZK9iaia9ibXwMLQFKIg/640?wx_fmt=jpeg&amp;from=appmsg"></section><p data-pm-slice="0 0 []"><span leaf=""><br></span></p><p data-pm-slice="0 0 []"><span leaf=""><span textstyle="">GSE232110</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: high throughput sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (8 adenoma vs 8 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集8例人结直肠腺瘤组织及其配对的癌旁未受累黏膜组织，利用高通量测序技术分析其表达谱，旨在为结直肠癌癌前阶段鉴定新的候选生物标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE236055</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 143 (14 进展者 vs 30 非进展者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究对14名进展为异型增生或癌症的溃疡性结肠炎患者和30名未进展的溃疡性结肠炎患者的非肿瘤性结肠黏膜活检组织进行转录组分析，旨在鉴定与溃疡性结肠炎向结直肠癌进展相关的早期分子事件和炎症特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE271719</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix HGU133-X3P arrays</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 98 (49 tumor vs 49 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在构建用于预测结直肠癌患者总生存期的表达风险模型，通过分析49对散发性结直肠癌患者的FFPE肿瘤组织与配对正常组织样本，使用Affymetrix HGU133-X3P芯片进行转录组分析，鉴定与预后相关的差异表达基因并开发风险评分模型。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE281917</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 140</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在识别黏液性结直肠癌的分子特征，基于RNA-seq数据开发预测模型，以改善风险评估并指导个性化治疗，研究样本包括黏液性和非黏液性结直肠癌组织。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE288482</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 52 (20 高表达肿瘤 + 20 低表达肿瘤 vs 12 配对正常对照)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为评估肿瘤中进化上较新的人类逆转录元件（Alu和LINE）的整合活性及其与转录活性的关系，研究选取了20个L1Hs和L1PA2高表达及20个低表达的结直肠癌肿瘤样本，并利用其配对的正常组织作为对照，通过高通量测序技术对特定元件的基因组侧翼进行测序，以在全基因组范围内寻找肿瘤特异的插入位点，探索其作为预后或诊断标志物的潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE261888</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 18 (结直肠癌 vs 健康)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究采集健康受试者和结直肠癌患者的结肠活检样本，通过高通量测序分析其全局基因表达谱，旨在探究INTS6基因突变与肿瘤的关联，并揭示结直肠癌肿瘤细胞代谢状态（如Warburg效应）及细胞外基质组织相关基因的显著变化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE251845</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 44 (21 EOCRC vs 22 LOCRC，均包含配对肿瘤与正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对21例早发性结直肠癌（EOCRC）和22例晚发性结直肠癌（LOCRC）患者的配对肿瘤组织及癌旁正常结肠组织进行RNA测序，旨在鉴定区分EOCRC的分子和遗传特征，包括差异表达基因、分子通路、预测细胞群、差异剪接事件和潜在新抗原。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE223119</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 40 (结直肠肿瘤 vs 癌旁非肿瘤组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探究代谢重编程在结直肠癌发生发展中的作用，通过比较结直肠癌肿瘤组织与配对癌旁非肿瘤组织的转录组，发现半胱氨酸代谢在肿瘤中高度富集，并通过多种机制促进结直肠癌的肿瘤生长和存活。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE143939</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: High throughput sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (6 tumor vs 6 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 提取6对结直肠癌组织及其配对的癌旁非癌组织的总RNA进行高通量测序，以展示结直肠癌中差异表达的环状RNA、长链非编码RNA和信使RNA。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE198692</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列芯片</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 20 (10 肿瘤 vs 10 正常)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在阐明内镜下切除的无蒂锯齿状腺瘤/息肉（SSA/P）的分子背景，对10对SSA/P的肿瘤-正常配对组织进行了全面的基因表达谱分析，通过聚类分析、基因集富集分析和结直肠癌共识分子亚型分类，发现SSA/P的基因表达谱与MSI-H结直肠癌高度相似，且CDX2表达显著下调，所有样本均在治疗前获取并立即新鲜冷冻以最小化烧灼效应。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE142279</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Next-generation sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 40 (20 tumor vs 20 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集20对结直肠癌肿瘤组织及其配对的癌旁正常结直肠组织，利用高通量测序技术进行转录组分析，旨在比较结直肠癌肿瘤与癌旁正常组织之间的基因表达差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE220148</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 114</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对在泰国Siriraj医院诊断和治疗的结直肠癌患者进行转录组研究，利用RNA-seq平台进行基因表达谱分析，旨在探究结直肠癌的转录组特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE196006</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 42 (肿瘤 vs 正常)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对早发性结直肠癌患者的配对正常结肠组织和肿瘤组织进行转录组分析，旨在识别参与癌变的基因表达程序，并探究MYC原癌基因在年轻患者结直肠癌发生中的驱动作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE184093</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 18 (肿瘤组 vs 癌旁正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌组织及其配对的癌旁组织学正常组织进行转录谱分析，旨在确定肿瘤与匹配正常样本之间长链非编码RNA和信使RNA的差异表达。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE157982</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 98 (干预后样本 vs 基线样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探究维生素D补充剂对人类结直肠上皮的体内转录组反应及其与抗肿瘤效应的关联，通过一项干预试验，对50名参与者每日口服3200IU维生素D补充剂12周，采集干预前后的血液和直肠正常粘膜活检样本，使用RNA-seq技术分析干预后活检组织的转录组变化，以评估候选基因和GO过程的富集情况，并寻找能预测该反应的血液生物标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE164191</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 121 (结直肠癌患者 vs 健康对照)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集结直肠癌患者与健康对照的外周血样本，利用微阵列技术进行基于血液的基因表达谱分析，旨在鉴定结直肠癌特异性的免疫相关转录组特征，以深入了解结直肠癌的发病机制并为潜在的免疫治疗策略提供新线索。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE146009</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Whole transcriptome sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 65 (40 tumor vs 25 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探究非裔美国人（AA）与高加索裔美国人（CA）结直肠癌患者肿瘤免疫学的差异，通过全转录组测序分析了来自AA和CA患者的共40例结肠癌肿瘤组织（各20例）与25例癌旁正常组织（AA 20例，CA 5例），并利用NanoString技术评估免疫细胞群，同时结合TCGA数据库进行验证，以揭示可能导致不同种族群体生存率差异的免疫防御机制缺陷。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE156355</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 全基因组微阵列</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (6 tumor vs 6 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集6例结直肠癌患者的肿瘤组织及其配对的癌旁正常结肠组织，使用全基因组微阵列技术比较其基因表达谱。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE141174</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (结直肠癌样本 vs 对照样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过微阵列技术对结直肠癌原发肿瘤、正常结肠及淋巴结样本进行全基因组基因表达分析，旨在研究结直肠癌样本与对照样本之间的基因表达差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE139814</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix human GeneChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (6 tumor vs 6 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集直肠癌组织及其配对癌旁非癌组织，使用Affymetrix人类基因芯片筛选差异表达的lncRNA和mRNA，旨在研究lncRNA在直肠癌发生发展中的作用并探索其作为新型肿瘤诊断或预后生物标志物的潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE137327</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 18 (9 tumor vs 9 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集9例人类结肠癌组织及其配对的癌旁正常组织，通过高通量测序技术获得基因表达谱，旨在分析结肠癌与正常组织之间的差异基因表达。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE100179</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Human Transcriptome Array 2.0 (HTA)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 60 (结直肠腺瘤与结直肠癌 vs 健康结肠)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 收集健康结肠、结直肠腺瘤和结直肠癌活检样本，使用HTA 2.0微阵列芯片分析全转录组表达水平，旨在研究从健康组织到腺瘤再到癌变过程中的基因表达变化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE128435</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 58 (肿瘤亚群 vs 正常组织和息肉)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在整合结直肠癌患者的转录组等多组学数据，数据集包含结直肠癌肿瘤亚群、正常组织以及息肉的基因表达谱，通过芯片技术进行分析，以探究不同病理亚型与正常组织及癌前病变之间的表达差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE115313</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 84 (42 tumor vs 42 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究对42例结肠癌患者的配对肿瘤组织和正常结肠黏膜样本进行基因表达谱芯片分析，其中23例患者合并2型糖尿病，旨在探究2型糖尿病作为结肠癌风险因素的作用，并发现糖尿病患者肿瘤及正常黏膜中均存在与癌症相关通路的失调，支持了糖尿病中癌症化区域的存在。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE110224</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 34 (17 tumor vs 17 matched normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集17例结直肠癌患者的原发性腺癌组织及其配对正常样本，使用微阵列技术监测全局基因表达变化，以揭示参与结直肠癌进展的关键生物学过程。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE110223</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 26 (13 tumor vs 13 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集13例结直肠癌患者的原发性腺癌组织及其配对的正常组织样本，使用微阵列技术监测全基因组表达变化，旨在揭示参与结直肠癌进展的关键生物学过程。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE122183</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列芯片</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 25 (结直肠癌组织 vs 癌旁正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究采集了结直肠癌组织及其配对癌旁正常组织，并检测了未感染具核梭杆菌的样本，使用微阵列芯片技术进行全基因组表达谱分析，旨在鉴定结直肠癌与癌旁正常组织之间差异表达的基因类别。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE113513</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix human GeneChip primeview array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 28 (14 tumor vs 14 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从接受手术切除的结直肠癌患者中获取14对癌组织和配对的癌旁非癌组织（距离至少5厘米），使用Affymetrix人类基因芯片进行表达谱分析，旨在鉴定结直肠癌组织与配对癌旁正常组织之间的差异表达基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE10945</span></span><span leaf=""><span textstyle="">4</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Agilent microarrays (Arraystar Human LncRNA Array v3.0)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (6 tumor vs 6 non-tumor)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对6名结直肠癌患者的配对结直肠肿瘤组织与非肿瘤组织进行微阵列分析，使用Agilent芯片检测其长链非编码RNA和信使RNA的表达谱，旨在鉴定可能驱动结直肠肿瘤发生的转录本。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE90627</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列芯片 (Expression profiling by array)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 128 (32例患者的多部位采样)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集32例直肠癌患者的癌组织以及距离肿瘤不同距离（1厘米、5厘米和切除样本近端）的组织学正常组织，使用微阵列芯片检测全局基因表达谱，旨在建立距离相关模型以研究与肿瘤邻近性相关的局部宿主因素变化，并鉴定与预后相关的基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE10483</span></span><span leaf=""><span textstyle="">6</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 20 (结直肠癌组织 vs 非肿瘤结直肠组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究采用新一代测序技术分析结直肠癌组织中lncRNA和mRNA的表达谱差异，通过与配对的非肿瘤结直肠组织比较，鉴定差异表达基因并进行功能富集分析，以探究lncRNA在结直肠癌发病机制和癌细胞生物学功能中的作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE74602</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 60 (30 tumor vs 30 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 分析结直肠癌患者中差异调控的基因，采集30对结直肠肿瘤组织及其配对的正常结肠组织样本，使用微阵列芯片进行表达谱分析，旨在鉴定与正常组织相比在肿瘤样本中上调或下调的差异表达基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE77953</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 58 (腺瘤、癌及转移灶 vs 正常结肠组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为了在转录组水平更好地理解结直肠癌进展，研究采集了正常结肠组织、癌前腺瘤、癌组织及转移灶样本，使用Affymetrix微阵列芯片进行转录组分析，旨在获取结直肠癌进展过程中基因表达的全局视图，并鉴定不同阶段之间显著差异表达的基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE41657</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 微阵列芯片</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 88 (正常粘膜 vs 腺瘤 vs 腺癌)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠正常粘膜、腺瘤和腺癌组织进行mRNA表达谱分析，旨在研究与结直肠癌发生相关的调控网络，并鉴定在癌前病变阶段即发生改变的基因特征，以探索影响结直肠癌预后的早期分子事件。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE50421</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Exon Array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 49 (结直肠肿瘤 vs 正常样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌肿瘤样本和正常样本进行外显子水平及基因水平的表达谱芯片分析，旨在研究体细胞拷贝数变异对基因功能的影响，并利用LIMMA分析鉴定差异表达基因及其在通路中的功能意义。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE50760</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 54 (36 tumor vs 18 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在鉴定具有不同进展和异质性的结直肠癌患者的预后标志物，对来自18名CRC患者的54个样本（正常结肠、原发性CRC和肝转移灶）进行RNA-seq测序，从数据中识别与CRC侵袭性相关的重要基因，并通过包括广义线性模型似然比检验在内的多种统计方法，鉴定出两个显著激活的调控因子，在验证队列中，这两个激活的调控因子是独立的危险因素和潜在的化疗敏感剂。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE39084</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 70 (具体分组信息未明确)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探究散发性早发性结直肠癌的临床病理特征、基因组和基因表达谱，并将其与其他已明确定义的结直肠癌组进行比较，以阐明其独特的肿瘤发生机制，为诊断和治疗提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE44076</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Human Genome U219 Arrays</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 246 (98 tumor vs 148 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集了98名结直肠癌患者的配对肿瘤组织和癌旁正常黏膜组织样本，以及50例健康结肠黏膜样本，使用Affymetrix微阵列芯片获取基因表达谱，旨在研究结直肠癌的转录组特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE44861</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 111 (肿瘤 vs 癌旁)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对来自结直肠癌患者的肿瘤组织和配对的癌旁非癌组织进行基因表达谱分析，旨在鉴定与NCF4基因rs5995355基因型相关的表达基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE312733</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Genomics Chromium</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4 (2 epithelial HO-1敲除 vs 2同窝对照)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用AOM-DSS诱导的结肠炎相关癌症小鼠模型，分离肠道上皮特异性Hmox1敲除小鼠及其同窝对照小鼠的结肠肿瘤细胞，通过10x Genomics Chromium平台进行单细胞RNA测序，旨在研究肿瘤微环境中基因型依赖的上皮细胞转录程序变化，重点关注应激适应反应、铁代谢和氧化应激调控。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE302903</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (12例结直肠癌患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 研究纳入了12例结直肠癌患者的肿瘤组织手术样本，所有病例均为连续入组且经至少两名病理学家细胞学或组织学确诊为直肠腺癌，无新辅助抗肿瘤治疗史，旨在通过单细胞RNA测序解析结直肠癌的肿瘤异质性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE254249</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 92 (治疗前后配对样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对局部晚期直肠癌患者治疗前后的匹配样本进行单细胞RNA测序、T细胞受体测序及空间转录组测序，描绘不同新辅助疗法诱导的肿瘤微环境动态变化，旨在阐明总新辅助治疗疗效背后的免疫重塑机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE289314</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞及空间转录组测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 14 (不同TNM分期结肠癌)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探索结肠癌不同TNM分期中肿瘤微环境的动态变化及其对免疫细胞功能的影响，识别与肿瘤进展相关的关键基因和信号通路，为精准诊断和个体化治疗提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE298084</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量单细胞转录组测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8 (结直肠癌原发灶与肝转移灶)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究对同时接受手术切除的结直肠癌（CRC）及其同步肝转移（CRLM）患者样本进行高通量单细胞转录组分析，旨在表征肿瘤微环境中肿瘤相关巨噬细胞（TAMs）的组织特异性转录组、表型和功能相关性，揭示其在早期肝转移进展中的作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE303434</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA_seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究通过新的CreERT2小鼠品系，在Nox1+或Npy1r+结肠干细胞中选择性失调Wnt信号，驱动结肠癌发生，并进一步结合激活致癌K-RAS和敲除Trp53，以研究这些干细胞作为结肠癌起源的作用并发展出晚期侵袭性癌症。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE273567</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞转录组测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 42 (新诊断结肠癌患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对新诊断结肠癌患者的42例手术切除结肠组织进行单细胞转录组分析，并结合空间转录组数据分析，旨在揭示具核梭杆菌感染与结直肠癌预后不良相关的细胞和分子机制，发现感染导致分泌型IgA功能失调并增加肿瘤内细菌负荷。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE302850</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞转录组测序 (基于摘要中提及的“single-cell transcriptomic datasets”)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 5 (基于AOM/DSS诱导的结肠炎相关癌症小鼠模型)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 在AOM/DSS诱导的结肠炎相关癌症小鼠模型中，通过整合配对转录组、蛋白质组、流式细胞术和细胞因子测量进行时间序列多组学分析，并辅以单细胞转录组和表观基因组数据集，旨在揭示免疫抑制的逐步演变轨迹，并鉴定ZG16作为关键的免疫调节因子及其对免疫检查点阻断疗效的影响。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE261388</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 10 (涵盖正常黏膜、炎性息肉、腺瘤性息肉和结直肠癌)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对10例人类结直肠标本进行单细胞RNA测序，样本涵盖结直肠癌发生发展过程中的四种组织类型，并结合免疫荧光染色、TCGA数据库及生存分析进行验证，旨在揭示驱动结直肠癌发生的动态分子景观及配体-受体基因与转录因子的重要性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE270745</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用ApcMin/+小鼠模型，结合特定细菌定植，研究产毒艰难梭菌对结直肠肿瘤发生的影响。通过单细胞RNA测序、空间转录组学和免疫荧光技术，分析有或无艰难梭菌暴露下结肠发育不良的分子空间组织，揭示了DMBT1在炎症与发育不良结肠中的双向调控。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE277669</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞转录组测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 1 (1例肿瘤)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集一例未经术前治疗、经病理诊断为腺癌的结直肠癌根治手术肿瘤组织样本，进行单细胞转录组测序，用于前瞻性观察性临床研究。数据分析流程包括原始数据质控、比对、细胞条形码校正、UMI解卷积、计数矩阵生成、质控指标筛选、数据标准化、高变基因鉴定，并使用t-SNE降维聚类、SingleR进行细胞注释、CellChat和NicheNet分析细胞通讯、monocle2进行细胞轨迹分析。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE282542</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 8</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌患者的肿瘤引流淋巴结进行单细胞RNA测序，解析其免疫景观，发现增大的非转移性淋巴结富含具有独特金属硫蛋白阳性特征的CD8+效应T细胞，这些细胞迁移至肿瘤部位并增强肿瘤免疫原性，研究旨在阐明其在结直肠癌抗肿瘤免疫中的作用及预后价值。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE278406</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-Seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6 (配对的治疗前后样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 前瞻性收集接受短程放疗联合新辅助免疫化疗的局部晚期直肠癌患者配对治疗前后的标本，进行多组学分析，通过单细胞测序鉴定与治疗完全缓解相关的TREM1+单核-巨噬细胞亚群，并探究其在放疗后肿瘤免疫激活中的作用机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE186854</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 10 (治疗组 vs 对照组)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌小鼠模型在对照条件及狼毒大戟与抗PD-1联合治疗下的肿瘤浸润T淋巴细胞进行单细胞RNA测序和TCR追踪，共分析22,590个T细胞，旨在揭示治疗过程中T细胞亚群的动态变化、异质性及其功能相互作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE276916</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-Seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 研究无丝氨酸/甘氨酸饮食对结直肠癌的影响，通过单细胞RNA测序分析该饮食如何抑制肿瘤生长、促进细胞毒性T细胞积累以增强抗肿瘤免疫，并揭示了肿瘤细胞中PD-L1的乳酸化是免疫逃逸的机制，表明联合饮食与免疫疗法具有临床潜力。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE245552</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 39 (18例同步性结直肠癌肝转移患者的多组学样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对18例同步性结直肠癌肝转移患者的130份样本进行多组学分析，整合外部数据集，利用单细胞RNA测序揭示了转移性与非转移性结直肠癌原发灶中非恶性细胞的差异分布，发现Th17细胞在转移性结直肠癌原发灶中富集，其分泌的TWEAK通过与肿瘤细胞上的Fn14受体结合促进上皮-间质转化，从而驱动肝转移。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE231559</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 26</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究是MD安德森癌症中心结直肠癌“登月计划”的一部分，使用单细胞RNA测序分析结直肠癌的细胞多样性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE212911</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究使用单细胞RNA测序技术分析模拟禁食饮食处理前后结直肠癌小鼠模型的肿瘤免疫微环境变化，旨在探究该饮食干预通过靶向IgA+细胞抑制肿瘤进展的关键靶点与分子机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE232525</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞转录组测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2 (治疗前 vs 治疗后)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对一例晚期结直肠癌患者在接受FOLFOX-贝伐珠单抗联合治疗前后的肿瘤样本进行单细胞转录组测序，旨在揭示该治疗方案引起的癌细胞重编程、免疫细胞功能改变及细胞间通讯重塑等分子机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE229163</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序 (scRNA-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过单细胞RNA测序分析结直肠癌肿瘤浸润γδ T细胞和结肠上皮内淋巴细胞的亚群与基因表达谱，旨在研究肿瘤微环境中γδ T细胞抑制性受体的表达模式、功能状态及耗竭特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE234511</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序 (scRNA-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用单细胞RNA测序分析具有基因突变的鼠结肠肿瘤内的细胞多样性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE205506</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 19例患者</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对19例错配修复缺陷/微卫星高度不稳定结直肠癌患者，在使用新辅助PD-1阻断剂治疗前后，利用单细胞RNA测序分析免疫和基质细胞的动态变化，以探究免疫检查点抑制剂诱导病理完全缓解的机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE224679</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens; Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 9</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用基因工程和致癌物诱导的小鼠肠道肿瘤模型以及一名遗传性息肉病患者的样本进行单细胞RNA测序，揭示了癌症起始伴随着以Ly6a (Sca-1)为标志的再生活性异常和Tacstd2 (Trop2)等胎儿肠道基因的重新激活，并通过Sox9基因失活实验证实其阻碍腺瘤形成、抑制再生与胎儿程序并恢复多谱系分化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE199726</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过单细胞RNA测序解析人结直肠癌中血管周围细胞的异质性，定义了13个周细胞亚群，并发现其中富含细胞外基质的TCF21高表达肿瘤周细胞亚群与患者转移潜能高度相关，旨在阐明该特定周细胞亚群通过重塑血管周围基质促进癌症转移的新机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE225857</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞及空间转录组测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 27个样本 (来自6例结直肠癌患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用单细胞和空间转录组测序技术，全面描绘了结直肠癌及其匹配的肝转移癌的细胞图谱。从6例患者的27个样本中，共获得了41892个CD45-非免疫细胞和196473个CD45+免疫细胞，旨在揭示原发性肿瘤与肝转移肿瘤之间的转录差异，从不同维度解析结直肠癌肝转移的发展过程。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE221575</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 5 (结直肠癌肿瘤、配对癌旁及肝转移组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌患者的肿瘤组织、配对癌旁正常组织以及肝转移组织进行单细胞RNA测序，旨在分析肿瘤免疫微环境的异质性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE158692</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Genomics</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6 (6个转移灶)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从5名不同患者的6个结直肠癌肝转移灶中分离癌细胞和成纤维细胞，使用10x Genomics平台进行单细胞测序，揭示了癌症相关成纤维细胞的不同亚群及其与癌细胞的配体-受体相互作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE183877</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 3</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过单细胞测序分析结直肠癌浸润B细胞的亚群与特征，以研究亮氨酸诱导的调节性LARS B细胞如何通过未知的特征和机制阻碍抗肿瘤免疫，从而促进结直肠癌的免疫逃逸。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE211257</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 收集具核梭杆菌感染的小鼠组织进行单细胞RNA测序，研究具核梭杆菌感染与结直肠癌组织中肿瘤相关巨噬细胞富集的相关性，并探讨其通过TLR4/MyD88/NF-κB/IL-6/STAT3通路增强巨噬细胞PD-L1表达、抑制CD8+ T细胞功能的机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE183916</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 5 (5 peritoneal metastasis)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对5例结直肠癌腹膜转移患者的样本进行单细胞测序，旨在全面表征腹膜转移的分子特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE201348</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 72 (包含息肉、正常组织和结直肠癌)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为描绘从健康结肠到癌前腺瘤再到结直肠癌的恶性转化过程中的细胞组成和状态变化，本研究从携带或不携带胚系APC突变的患者中采集了息肉、正常组织和结直肠癌样本，生成了单细胞染色质可及性谱和单细胞转录组数据，发现大部分息肉和结直肠癌细胞呈现干细胞样表型，并定义了这些干细胞样细胞从稳态进展至结直肠癌过程中的表观遗传和转录变化的连续谱。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE200997</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 基于液滴的单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 23 (16例未经治疗的结直肠癌患者组织 vs 7例癌旁正常结肠组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对16例不同种族的、未经治疗的结直肠癌患者组织样本和7例癌旁正常结肠组织样本进行基于液滴的单细胞RNA测序，共获得49,589个单细胞，旨在高分辨率描绘肿瘤及微环境细胞内的细胞多样性与异质性，以完善结直肠癌的分类和临床分层。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE196964</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Genomics</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 11 (配对样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 获取配对的人结肠与肿瘤活检组织制备成单细胞悬液，使用10x Genomics平台进行液滴封装和文库构建，旨在通过单细胞测序分析结直肠癌组织与正常结肠组织的差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE164522</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 17 (肝转移性结直肠癌、非转移性原发性肝癌及结肠癌患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对肝转移性结直肠癌患者的自体临床样本，以及非转移性原发性肝癌和结肠癌患者的样本进行了系统的单细胞分析，旨在解析不同因素如何塑造肿瘤微环境，特别是比较原发灶与转移灶的免疫表型联系。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE161277</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Genomics (GPL24676)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 13 (包含息肉、癌、癌旁及正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对患者匹配的血液、正常组织、癌旁组织、息肉和癌组织样本进行单细胞RNA测序，旨在解析结直肠癌发生过程中上皮细胞和免疫细胞的演变。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE188711</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6 (3 left-sided vs 3 right-sided)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过单细胞RNA测序分析了来自3例左半结肠癌和3例右半结肠癌患者的共27,927个细胞的转录组，旨在解析不同原发部位结直肠癌在肿瘤微环境、免疫细胞状态和预后标志物等方面的差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE178318</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 15 (原发结直肠癌、配对的肝转移灶及血液样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌患者的原发灶、配对的肝转移灶及血液样本进行单细胞转录组测序，系统分析了111,292个单细胞，旨在揭示结直肠癌肝转移肿瘤微环境的复杂性、多样性及其对术前化疗的响应，包括免疫细胞和基质细胞的重编程变化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE178341</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 62 (34例MMRd vs 28例MMRp)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从28例错配修复功能正常（MMRp）和34例错配修复缺陷（MMRd）的结直肠癌患者中，对肿瘤及癌旁正常组织共371,223个细胞进行单细胞转录组测序，通过无监督分析鉴定了7个细胞谱系中的88个细胞亚群及204个基因表达程序，旨在揭示两种类型结直肠癌在免疫反应模式、转录及空间重编程方面的关键差异。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE163974</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: SMART-seq2 (并辅以10x Genomics验证)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2例结直肠癌原代样本</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过对2例原发性结直肠癌样本进行SMART-seq2单细胞测序，并在同一细胞中同时测量端粒长度与转录组，系统评估了结直肠癌干细胞的状态，其转录组结果通过10x Genomics高通量单细胞测序进行了独立验证。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE14677</span></span><span leaf=""><span textstyle="">1</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序 (scRNA-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 20</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌患者的免疫和基质细胞群体进行单细胞RNA测序分析，以鉴定肿瘤微环境中关键的巨噬细胞和树突状细胞亚群，并揭示其细胞互作机制，同时在小鼠模型中验证了针对髓系细胞的免疫疗法（抗CSF1R和CD40激动剂抗体）的作用机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE148345</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 未明确指定（高通量测序）</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 1441</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在揭示结直肠癌（CRC）细胞生物合成能力的异质性，发现核糖体DNA转录和蛋白质合成主要发生在定位于特定生态位的有限肿瘤细胞亚群中，而其余肿瘤细胞因分化而不可逆地丧失生物合成能力。通过分析POLR1A高表达细胞群，证明其遗传消融可导致CRC生长停滞，并阐明升高的生物合成水平定义了LGR5+和LGR5-肿瘤细胞的干性，从而揭示了CRC中基于核糖体DNA转录和蛋白质合成差异能力的简单细胞层级结构。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE144735</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Genomics 3' scRNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 18 (6例患者，包含肿瘤核心区、边界区及配对正常黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对6例比利时结直肠癌患者的肿瘤核心区、边界区及配对正常黏膜组织进行10x Genomics 3'单细胞RNA测序，共获得27,414个细胞，旨在解析结直肠癌内在的癌细胞特征及其周围微环境，描绘全面的细胞图谱和潜在的细胞间相互作用，为治疗策略的开发提供资源。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE132465</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞3' RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 33 (23 肿瘤 vs 10 正常)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为理解结直肠癌内在的癌细胞特征及其周围微环境，对来自23名韩国结直肠癌患者的23个原发性肿瘤组织和10个匹配的正常粘膜样本中的63,689个细胞进行了单细胞3' RNA测序，描绘了结直肠癌全面的细胞图谱和潜在的细胞相互作用，为治疗策略的开发提供了宝贵资源。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE132257</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 10 (5 结直肠癌 vs 5 匹配正常黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为评估三种不同组织解离方案及新鲜与冻存细胞制备方法，对来自2例结直肠癌患者的癌组织及远端正常组织解离物进行单细胞RNA测序，共分析了10个样本制备物（5个原发结直肠癌和5个匹配的正常黏膜）中的18,409个细胞，结果表明不同样本制备方法回收的细胞比例高度一致。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE142694</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 2</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过单细胞RNA测序分析结直肠癌进展过程中肿瘤浸润的先天淋巴细胞，鉴定出六个具有独特特征的ILC亚群，并揭示了ILC1s在晚期CRC中的功能抑制性转化、ILC2s促进肿瘤进展的亚群以及ILC3s向ILCregs转分化的过程，旨在阐明肿瘤浸润ILC如何调节肿瘤发展。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE92432</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 单细胞RNA测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 10例</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究开发并优化了一套适用于人结直肠癌组织的单细胞测序系统，整合了组织消化、活单细胞分选、单细胞RNA扩增与测序及生物信息学分析技术，成功应用于人结直肠癌组织样本的单细胞转录组测序，旨在为结直肠癌的单细胞水平精准研究提供可靠方法。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GS</span></span><span leaf=""><span textstyle="">E1093</span></span><span leaf=""><span textstyle="">08</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: STRT-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4例患者（腺瘤、腺癌、癌旁正常组织及淋巴结转移灶）</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对4例携带胚系APC突变的腺瘤性息肉病患者，采集其匹配的息肉、腺癌、癌旁正常结肠组织及一处淋巴结转移灶，利用改进的STRT-seq协议分析了超过4000个单细胞，旨在揭示APC突变引发结直肠癌的致病机制与异质性，并比较腺瘤、腺癌与正常组织间的转录组异同及突变积累过程。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE280312</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Visium HD</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (结直肠癌与癌旁正常黏膜组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用10x Visium HD平台对福尔马林固定石蜡包埋的人结直肠癌及癌旁正常黏膜组织进行基于探针的空间转录组分析，实现了单细胞分辨率的全转录组空间图谱构建。研究通过整合来自同一FFPE样本连续切片的单细胞图谱数据，全面表征了肿瘤微环境，特别是肿瘤边缘区域的免疫细胞类型，并识别了具有不同基因表达谱和空间定位的促肿瘤巨噬细胞亚群以及具有克隆扩增特征的T细胞群体。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE280311</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Visium HD</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (结直肠癌组织与癌旁正常黏膜组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用10x Visium HD平台对来自福尔马林固定石蜡包埋样本的人结直肠癌及癌旁正常黏膜组织进行高分辨率空间转录组分析，并利用同一样本块的连续切片生成单细胞图谱，整合数据以全面表征肿瘤微环境（特别是肿瘤边缘）的免疫细胞组成，识别了具有不同空间分布和基因表达谱的巨噬细胞亚群及克隆性扩增的T细胞群。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE270745</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 空间转录组</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 在ApcMin/+小鼠模型中，结合单细胞RNA测序、空间转录组学和免疫荧光技术，研究产毒艰难梭菌对结肠肿瘤发生的影响，通过比较暴露与未暴露于艰难梭菌的小鼠，定义了结肠发育不良的分子空间组织，并发现DMBT1在发育不良灶中显著下调。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE240623</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: HTG EdgeSeq Precision Immuno-Oncology Panel</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 26 (13 EOCC vs 13 LOCC)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在解析散发性早发性结直肠癌（EOCC）中肿瘤上皮细胞与癌症相关成纤维细胞（CAF）独特的空间转录组和蛋白质组特征。将散发性结直肠癌FFPE组织样本分为早发性（&lt;50岁）和晚发性（≥50岁）两组，共对13例LOCC患者和13例EOCC患者的样本进行了HTG EdgeSeq精准免疫肿瘤学Panel分析，并结合生物信息学分析与功能实验，以表征EOCC肿瘤侵袭前沿的FAP阳性CAF。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE240531</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Nanostring GeoMx DSP</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 112个感兴趣区域</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究针对散发性早发性结直肠癌（EOCC）与晚发性结直肠癌（LOCC）的FFPE组织样本，使用Nanostring GeoMx数字空间分析技术对112个感兴趣区域进行空间转录组和蛋白质组分析，旨在揭示肿瘤上皮细胞和癌症相关成纤维细胞（CAFs）独特的空间分子特征，并结合生物信息学分析与功能实验，表征EOCC肿瘤侵袭前沿的FAP(+) CAFs。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE226997</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 10x Visium</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4例患者</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对4例结直肠癌患者的原发肿瘤组织进行Visium空间转录组测序，旨在揭示结直肠癌中癌细胞的空间分布及其差异基因表达模式。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE288652</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: EPIC v1 Human Methylation Beadchip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 32 (13 low-grade vs 19 high-grade adenoma)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究为探索结直肠癌发生早期的表观遗传动力学，使用EPIC甲基化芯片检测了13例低级别和19例高级别结直肠腺瘤的甲基化谱，并结合已发表的206例非肿瘤结肠组织和24例结肠腺癌数据，通过差异甲基化分析追踪从非肿瘤组织到腺瘤直至腺癌的甲基化演变过程。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE284325</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序甲基化分析 (Base-pair resolution)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究针对美国早发性结直肠癌发病率上升且在少数族裔中比例不均的背景，构建了来自西班牙裔和非裔美国患者的早发性结直肠癌队列的高分辨率DNA甲基化组图谱，旨在揭示其与晚发性结直肠癌患者不同的表观遗传景观，并识别在少数族裔队列中特有的代谢基因表观遗传改变，为早发性结直肠癌的发病机制和生物标志物发现提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE282666</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 51 (患者样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在探究50岁以下人群中生物年龄加速与结肠癌前息肉（管状腺瘤和无蒂锯齿状腺瘤）的关联，以解释早发性结直肠癌的上升趋势。研究利用51名接受结肠镜检查的50岁以下个体的外周血样本，通过检测全基因组特定CpG位点的DNA甲基化水平来确定生物年龄和年龄加速指标，并使用逻辑回归分析评估年龄加速与癌前息肉存在之间的关联。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE220160</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Infinium HumanMethylationEPIC BeadChip array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (8 CRC vs 8 polyp)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为发现用于结直肠癌诊断的cfDNA甲基化标志物，本研究首先使用EPIC甲基化芯片对8例结直肠癌组织和8例息肉组织进行全基因组甲基化分析以鉴定差异甲基化CpG位点，随后在更大的组织队列中验证，并通过LASSO和随机森林模型筛选出四个组织甲基化标志物，构建了能有效区分结直肠癌与息肉的诊断预测模型和甲基化诊断评分，最后在血浆验证队列中确认了单个cfDNA甲基化标志物cg27541454在结直肠癌中的高甲基化状态，表明该评分可稳健检测结直肠癌，且cg27541454可能成为有前景的非侵入性早期诊断生物标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE213402</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RRBS</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 20 (10对配对的原发癌与肝转移灶)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对10名结直肠癌患者的配对原发肿瘤和肝转移灶样本进行简化代表性亚硫酸盐测序和RNA测序，旨在解析肿瘤进展和转移过程中的关键分子事件。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE150333</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by high throughput sequencing</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 48 (GF, SPF, Il10-/-/SPF, AOM处理组等)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 研究微生物组对结直肠黏膜DNA甲基化的影响，使用无菌小鼠、无特定病原体小鼠以及易发生炎症和肿瘤的Il10-/-小鼠模型，并比较了衰老和结肠致癌物氧化偶氮甲烷暴露引起的甲基化变化，发现微生物组影响的CpG位点在结直肠癌的甲基化改变中富集。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE119526</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 96</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为改善I-II期结直肠癌患者的复发风险预测，本研究通过全基因组甲基化芯片分析，旨在从新建立的甲基化谱中鉴定可作为生物标志物的CpG位点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE224222</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 11</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究首次报道了一例Beckwith-Wiedemann综合征与早发性结直肠癌共存的病例，通过对患者体细胞和种系水平的遗传与表观遗传分子病变进行分析，为表观遗传改变在已有遗传损伤的组织中协同促进肿瘤发生的假说提供了支持。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE184494</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 48</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌组织进行甲基化芯片分析，以研究结直肠癌的甲基化特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE159898</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium MethylationEPIC (850K) BeadChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 44 (21对配对肿瘤与正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Illumina EPIC 850K甲基化芯片分析21例中国结直肠癌患者的配对肿瘤与正常组织，通过筛选差异甲基化探针、区域及基因功能区域，结合功能注释和通路富集分析，旨在开发用于结直肠癌诊断和预测卡培他滨化疗相关不良事件的整合甲基化标志物系统。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE13266</span></span><span leaf=""><span textstyle="">8</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 37 (局部晚期直肠癌患者)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究对接受新辅助放化疗（基于5-氟尿嘧啶和放疗）及手术的局部晚期直肠癌患者进行DNA甲基化分析，旨在通过治疗前活检组织的甲基化谱构建分类器，以预测患者对治疗是否达到病理完全缓解，从而为制定个体化治疗策略提供依据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE109202</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: MeDIP-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 15</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究通过甲基化DNA免疫共沉淀测序分析结直肠肿瘤样本，旨在揭示差异表达的长链非编码RNA及错误转录的非编码转录本在差异表达或错误转录的编码转录本启动子区具有潜在DNA结合位点，同时相关位点也存在差异甲基化DNA区域的获得与丢失，且这些转录本与甲基化区域均表现出显著的病例间异质性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE151318</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量测序甲基化谱分析</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 15 (结直肠癌原发瘤及淋巴结转移灶 vs 癌旁正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对伴有淋巴结转移的结直肠癌患者样本进行全基因组DNA甲基化测序，发现肿瘤样本在CG贫乏的非CpG岛区域存在整体甲基化丢失，而CpG岛整体甲基化水平增加。通过差异甲基化分析，鉴定出60个潜在的生物标志物，这些标志物在原发瘤和转移灶中相比癌旁正常组织的DNA甲基化水平均增加超过20%。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE149282</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Infinium DNA MethylationEPIC assay</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 24 (结直肠癌组织 vs 正常结肠组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究利用Infinium DNA MethylationEPIC芯片检测结直肠癌组织，探究开放染色质区域的甲基化组特征，旨在发现癌症特异性甲基化模式及潜在生物标志物，通过严格分析鉴定出2187个在结直肠癌中显著差异甲基化的开放染色质区域，其中多数为低甲基化，并通过无监督层次聚类和ROC分析筛选出能有效区分癌与正常组织的高鉴别性探针。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE139404</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina HumanMethylation450 (450K)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 60 (40 adenoma vs 20 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究通过全基因组DNA甲基化芯片分析，旨在鉴定结直肠癌发展的早期生物标志物，对20例正常组织、18例低级别腺瘤和22例高级别腺瘤样本进行检测，以探索癌前病变阶段的甲基化变化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE12643</span></span><span leaf=""><span textstyle="">3</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: WGBS</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 4</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为探究DNMT3B是否在人类结直肠癌中驱动BRAFV600E突变相关的CpG岛甲基化表型，本研究对4个人类样本进行了全基因组亚硫酸盐测序分析，结合TCGA数据分析及体外实验，旨在阐明DNMT3B的致癌活性及其与BRAFV600E和CIMP表型的关系。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE98531</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation27 BeadChip (27k)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 16 (8 tumor vs 8 paired normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对8例结肠癌肿瘤组织及其配对的癌旁正常黏膜组织进行全基因组DNA甲基化分析，使用Illumina 27K甲基化芯片检测约27,000个CpG位点，旨在解析结肠癌发生过程中CpG高甲基化的发展，区分年龄环境相关与遗传驱动的甲基化模式，并揭示BRAFV600E突变通过抑制TET去甲基化酶驱动CIMP表型的机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE129364</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina HumanMethylation 450K BeadChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 72 (49 腺瘤 vs 3 正常黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究收集了72例福尔马林固定石蜡包埋样本，包括30例无复发的原发性结直肠腺瘤、19例在原位复发的原发性腺瘤、10对匹配的“原发-复发”腺瘤对以及3例正常黏膜样本，使用Illumina 450K甲基化芯片进行全基因组DNA甲基化分析，旨在揭示复发性与非复发性结直肠腺瘤之间的差异甲基化模式，并探索甲基化谱与组织学亚型之间的关联。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE37872</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 18 (2例患者的配对样本)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对两例结直肠癌患者的配对原发肿瘤组织、癌旁黏膜组织和血液样本进行DNA甲基化芯片分析，旨在鉴定与结直肠癌发生相关的癌症特异性甲基化靶标。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE109507</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Infinium HumanMethylation450 BeadChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 23 (23 tumor)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对23例家族性腺瘤性息肉病肿瘤组织进行Illumina HumanMethylation450甲基化芯片检测，旨在分析其DNA甲基化谱。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE87096</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: MeDIP-seq, hMeDIP-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 36 (18 tumor vs 18 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采集6例结直肠癌患者的肿瘤及配对癌旁正常组织共12例样本，通过甲基化DNA免疫共沉淀测序和羟甲基化DNA免疫共沉淀测序进行全基因组甲基化与羟甲基化分析，并整合RNA-seq转录组数据，旨在筛选结直肠癌的表观遗传生物标志物并阐明其致癌机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE102645</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Agilent SureSelect Methyl-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 6 (AOM+DSS诱导组 vs 对照组 vs 姜黄素治疗组)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用AOM和DSS诱导的小鼠结肠炎相关结肠癌模型，通过Agilent SureSelect Methyl-seq对对照组、AOM+DSS诱导组及AOM+DSS诱导加姜黄素治疗组的上皮细胞进行单碱基分辨率甲基化谱分析，研究炎症驱动结肠癌发生过程中的甲基化改变以及姜黄素的干预作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE110537</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: WGBS (Methylation profiling by high throughput sequencing)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 3</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过对包括恶性与正常样本在内的多个样本进行基因组、甲基化组和转录组水平的综合分析，发现BRAF-V600E激活突变驱动了独特的无蒂锯齿状息肉特异性DNA甲基化谱的生成，旨在鉴定可用于非侵入性粪便DNA检测的早期诊断标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE95654</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RRBS</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 40 (20 KRAS突变病变样本 vs 20匹配正常黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究结合激光捕获显微切割与简化代表性亚硫酸盐测序，对10例健康个体的KRAS突变型异常隐窝病灶、10例结直肠癌患者的KRAS突变型肿瘤及其各自匹配的正常黏膜样本进行甲基化分析，旨在鉴定结直肠癌最早前体阶段的癌症相关DNA甲基化变化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE101764</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina HumanMethylation450k BeadChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 261 (112 结直肠癌 vs 149 癌旁黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 在ColoCare项目中，使用Illumina 450K甲基化芯片对112例结直肠癌组织和149例癌旁黏膜组织进行全基因组DNA甲基化分析，旨在研究DNA甲基化谱与患者特征、生活方式及环境暴露因素之间的关系。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE77635</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: 高通量甲基化测序</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 39 (11 LST vs 28 正常黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对11例结直肠侧向发育型肿瘤及其配对的正常黏膜样本进行全基因组高通量甲基化测序和表达谱测序等多组学分析，旨在揭示这种罕见恶变的结直肠腺瘤的分子特征，并与结直肠癌进行对比，以理解其生物学特性及向癌症进展的机制。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE68060</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Infinium Human Methylation 450 BeadChip</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 103 (36 SAC vs 34 CC)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在分析结直肠癌中锯齿状腺癌亚型的甲基化组特征，使用Illumina 450K甲基化芯片检测了103例来自西班牙和芬兰患者的结直肠组织样本，比较了36例锯齿状腺癌与34例配对的传统腺癌的甲基化谱，以鉴定该亚型特有的生物学功能和差异甲基化基因，并通过焦磷酸测序、甲基化特异性PCR、qPCR和免疫组化等方法对候选基因进行了验证。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE57527</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: WGBS (Bisulfite-seq)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 9</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用AOM/DSS小鼠模型，通过全基因组亚硫酸盐测序在单碱基分辨率下表征结肠炎和结肠癌的甲基化组，旨在揭示炎症诱导的DNA高甲基化区域在结直肠癌发生中的作用。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE34068</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 15</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对增生性息肉病综合征（HPS）患者的息肉组织和无病组织进行全基因组DNA甲基化分析，以研究这种与结直肠癌风险增加相关的疾病中，从癌前息肉到恶性肿瘤转变过程中CpG岛甲基化表型（CIMP）的时间变化，重点关注包括Wnt信号通路负调控因子在内的多个肿瘤抑制基因的单等位基因甲基化模式。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE33181</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Infinium Methylation Assay (Illumina)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 48 (结直肠癌患者配对肿瘤与正常组织)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在评估经连接修复法改良的Infinium甲基化检测平台对结直肠癌患者福尔马林固定石蜡包埋组织进行全基因组甲基化分析的可行性，通过比较同一患者的配对新鲜冷冻与FFPE结肠组织样本，评估了位点特异性相关性及肿瘤特异性差异甲基化位点的一致性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE52573</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation27 BeadChip (HM27)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 41 (12 多发性 vs 29 单发性)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究使用基于人群的EPICOLON II队列，对12例同步性多发性结直肠癌患者与29例年龄、性别和肿瘤位置匹配的单发性结直肠癌患者的肿瘤样本进行Illumina HM27全基因组甲基化芯片分析，旨在描述区分多发性与单发性结直肠癌的表观遗传特征，并通过Methylight验证关键差异甲基化基因，同时评估CIMP状态、KRAS/BRAF突变及微卫星不稳定性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE40055</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium 27k Human DNA Methylation BeadChip v1.2</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 42 (包含正常结肠上皮、腺瘤和结直肠腺癌)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Illumina 27k甲基化芯片对新鲜冷冻的结直肠组织样本进行全基因组DNA甲基化分析，覆盖约27,000个CpG位点，旨在评估正常结肠上皮、腺瘤和结直肠腺癌中的甲基化变化，研究发现影响转录的癌症相关甲基化改变在结直肠癌的非CpG岛启动子区域与CpG岛启动子区域几乎同样频繁发生。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE43369</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina GoldenGate Methylation Cancer Panel I</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 194 (92 tumor vs 92 paired normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为筛选结直肠癌诊断相关的DNA甲基化生物标志物，使用Illumina GoldenGate甲基化癌症Panel I对92例结直肠癌患者的肿瘤组织及其配对的癌旁正常黏膜进行分析，旨在从807个癌症相关基因中鉴定出可用于非侵入性诊断结直肠癌的候选甲基化标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE37740</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation27</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 21 (18个代表84个结直肠癌样本的DNA池 vs 3个代表70个癌旁正常组织的DNA池)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对代表84例结直肠癌样本的18个DNA池（根据高、中、低甲基化表型分组）以及代表70例癌旁正常结肠组织的3个DNA池，使用Illumina 27K甲基化芯片进行全基因组范围的DNA甲基化谱分析，旨在研究结直肠癌中不同甲基化表型与CpG岛甲基化表型的关系。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE39446</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina GoldenGate® methylation array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 119 (91 CRC vs 28 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Illumina GoldenGate甲基化芯片对91例连续收集的结直肠癌样本和28例匹配的正常结肠粘膜样本进行检测，评估807个癌症相关基因中1505个CpG位点的DNA甲基化状态，旨在揭示具有不同临床病理和分子特征的结直肠癌亚群。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE29490</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium HumanMethylation27 BeadChip (27k)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 48 (结直肠癌肿瘤组织 vs 癌旁健康结肠黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对结直肠癌患者的肿瘤组织及癌旁健康结肠黏膜进行全基因组DNA甲基化分析，使用Illumina 27k甲基化芯片检测覆盖14,475个基因的27,578个CpG位点的甲基化谱，以研究结直肠癌的甲基化特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE26758</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Mus musculus</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RRBS</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 12 (6 Dnmt3b转基因 vs 6 野生型对照)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对表达Dnmt3b转基因的小鼠与野生型对照小鼠的结肠上皮细胞进行简化代表性亚硫酸盐测序，以分析其全基因组甲基化状态，发现Dnmt3b表达导致一部分“甲基化敏感”基因发生显著的从头甲基化，这些基因与人类结直肠癌中发生甲基化的基因高度一致，表明该小鼠模型的结肠上皮细胞甲基化模式能高置信度地预测人类结直肠癌的DNA甲基化。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE25062</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Illumina Infinium DNA methylation assay (27,578 CpG sites)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 154 (125 tumor vs 29 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为鉴定结直肠癌的DNA甲基化亚型，使用Illumina Infinium甲基化检测平台对125例结直肠癌肿瘤样本和29例组织学正常的癌旁结肠组织样本进行了全基因组规模的DNA甲基化谱分析，该平台评估了位于14,495个蛋白质编码基因启动子区域的27,578个CpG位点的甲基化状态，并通过模型聚类分析确定了四个具有独特遗传和临床特征的DNA甲基化亚型。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE21181</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 26 (18 tumor vs 8 normal)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用甲基化芯片对18例结肠肿瘤样本与正常结肠黏膜进行差异甲基化分析，通过样本与参考面板的对数比值进行检测。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE17648</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Methylation profiling by array (beadchip array)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 44 (结直肠癌组织 vs 癌旁正常黏膜)</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 采用基于微珠芯片的甲基化分析技术，对结直肠癌组织和癌旁正常黏膜中超过14,000个基因的27,578个CpG位点进行甲基化谱分析，旨在鉴定结直肠癌中常见的异常甲基化基因谱，并发现了621个在肿瘤中显著高甲基化的CpG位点，通过焦磷酸测序验证了包括ADHFE1、TFPI2等在内的候选甲基化标记物，为结直肠癌的诊断和治疗应用提供了潜在靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE271719</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray (HGU133-X3P)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 98</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在构建基于表达的预后风险模型以预测结直肠癌患者的总生存期，分析了49对散发性结直肠癌FFPE肿瘤与正常组织样本，通过转录组分析结合公共数据集筛选候选基因，利用单变量Cox回归确定与OS相关的关键基因，并开发了结合基因表达与患者分期的预后风险评分，在两个独立GEO数据集中进行了验证，成功将患者分为具有显著OS差异的低风险和高风险组。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE281917</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 140</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 基于RNA-seq数据和Cox回归模型，开发了一个反映粘液性结直肠癌特征的标志物，该标志物在预测结直肠癌复发和指导个性化治疗方面显示出强大的预测能力和临床实用性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE251845</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 44</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对21例早发性结直肠癌和22例晚发性结直肠癌患者的匹配肿瘤及正常组织进行RNA测序，通过识别差异表达基因和可变剪接事件，开发了一个预测结直肠癌患者总生存期的八基因评分。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE237684</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 61</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究比较了阿拉巴马州非裔美国人、俄克拉荷马州美洲印第安人以及两个州白人的结直肠癌转录组谱，旨在揭示可能解释不同种族群体间结直肠癌发病率和死亡率差异的分子特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE40492</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 245</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对来自德国直肠癌研究组多中心试验的患者进行全基因组表达谱分析，旨在开发预测术后淋巴结状态和无病生存期的分子分类器，并在独立前瞻性样本集中验证其预后预测性能。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE216616</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 298</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对298例晚期直肠癌患者新辅助放化疗前的活检组织进行RNA测序分析，通过多变量Cox分析评估细胞毒性淋巴细胞评分与无复发生存和总生存的独立关联，旨在预测治疗反应和生存结局。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE207194</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 61</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在评估CD226对接受化疗和根治性手术的结直肠癌肝转移患者肿瘤浸润淋巴细胞的预后价值。通过RNA-seq分析原发性和肝转移性结直肠癌样本，发现CD226高表达与强免疫浸润相关。多变量Cox回归分析显示，CD8 T细胞上的CD226表达是一个独立的预后因素，其预后价值在验证数据集中被证实特异于肝转移灶。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE211576</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 54</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对54例新发转移性BRAF V600E突变结直肠癌患者进行微阵列分析，研究肿瘤微环境中补体激活与总生存期（OS）的关联，发现其与不良预后显著相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE197802</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray (SNP and gene expression)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 88</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 该研究旨在通过整合单核苷酸多态性（SNP）和基因表达（GE）微阵列数据来检测基因组和转录组改变，以增强结直肠癌的预后预测；利用具有同步增益和丢失的基因开发了一个预后特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE175433</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Nanostring immune profiling (Expression profiling by array)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 79</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用Nanostring免疫分析技术对79例早发（40例）与晚发（39例）结直肠癌患者的FFPE手术标本进行mRNA表达分析，研究肿瘤免疫微环境差异，并发现CFD和SAA1表达升高与更差的无进展生存期相关，C7表达升高与更差的总生存期相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE161158</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 250</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 在包含250例结直肠癌患者的发现数据集中，通过分析BMP/Wnt靶基因表达与SMAD4表达的关联，鉴定出一个SMAD4调控的基因谱，并测试其与患者结局（无病生存期）的关联，旨在建立预测II期和III期结直肠癌患者预后的模型。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE122246</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 24</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对接受标准辅助化疗的III期结直肠癌患者进行RNA测序，根据无病生存期筛选预后极端队列，旨在识别和验证预测化疗反应的分子生物标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE143985</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 91</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 利用从整个组织切片提取的RNA，开发了一个与肿瘤出芽等级（一种去分化的镜下发现）相关的新分子特征，并使用内部数据集和独立的公共数据集揭示了其与高复发风险的相关性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE107422</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 110</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在识别预测结直肠癌患者复发的基因集，对110例原发性结直肠癌样本进行RNA-seq分析，通过包括广义线性模型似然比检验在内的多种统计方法，识别出与复发相关的10个关键基因，并在验证队列中证实由这10个基因构成的风险分类器是结直肠癌的独立风险因素。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE101481</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array (NanoString nCounter)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 91</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 开发并验证一种低成本多重生物标志物检测方法（NanoCRCAssigner），用于对结直肠癌样本进行分子分型，研究分析了来自三个队列的未治疗新鲜冷冻样本（n=57）和一个FFPE样本队列（n=24），分型结果与已知的分子、突变特征以及包括总生存期在内的临床特征相关联，以证明检测方法的有效性。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE103479</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 156</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对156例II期和III期结直肠癌患者进行基因表达谱分析，旨在评估不同分子亚型（CMS和CRIS）患者从基于5-FU的辅助化疗中获益的情况，研究包含患者的5年总生存期（OS）数据。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE72969</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 56</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对56例转移性结直肠癌患者进行微阵列分析，研究分子亚型与治疗反应的关系，其中发现一个亚群接受FOLFIRI一线治疗的患者总生存期显著延长，表明分子分型对制定个体化治疗策略的价值。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE72968</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 68</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对68例转移性结直肠癌患者进行微阵列分析，研究分子亚型与治疗反应的关系，其中包含患者接受一线FOLFIRI或FOLFOX方案治疗后的总体生存数据，用于验证分子亚型对化疗和靶向治疗反应的预测价值。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE58394</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 300</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 收集300例II期结直肠癌患者样本进行微阵列分析，旨在基于基因表达特征对患者进行预后分层，通过多变量Cox分析验证了预测预后的标志物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE83889</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 136</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 比较了101例接受FOLFOX辅助化疗的III期结直肠癌组织与35例配对的非肿瘤结肠黏膜组织的mRNA表达谱，旨在研究不同分子亚型中可用于预测预后的分子标志物基因。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE71222</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 152</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对152例I-III期结直肠癌患者进行微阵列分析，旨在鉴定新的预后生物标志物，研究评估了TNIK基因表达与患者无复发生存期（RFS）的关系，发现高表达与较差的RFS显著相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE64258</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray; SNP array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 297</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 该研究为SuperSeries，包含多个子系列，旨在评估Traf2-和Nck-相互作用激酶（TNIK）在结直肠癌中过表达的预后意义。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE64256</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 125</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对153例结直肠癌患者进行激光显微切割和寡核苷酸芯片分析，鉴定与远处转移相关的候选基因，并通过免疫组化在271例患者中验证，发现TNIK蛋白过表达与较差的OS和RFS显著相关，是CRC复发的独立风险因素。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE50760</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: RNA-seq</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 54</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在鉴定结直肠癌患者的预后标志物，通过RNA-seq分析了来自18名患者的54个样本（包括正常结肠、原发CRC和肝转移灶），并利用包括广义线性模型似然比检验在内的多种统计方法，鉴定了与CRC侵袭性相关的显著基因，在验证队列中，两个被激活的调节因子被确定为独立的危险因素和潜在的化疗敏感药物。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE39582</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray (U133Plus2)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 585</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对443例结肠癌和19例非肿瘤结直肠黏膜进行mRNA表达谱分析，并在独立队列中验证，定义了六个具有不同临床、分子和生存特征的分子亚型，其生物学相关性通过生存率的显著差异得到证实。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE27854</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 115</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对115例结直肠癌患者进行mRNA表达谱分析，以鉴定与远处转移相关的新生物标志物，研究发现NUCKS1蛋白过表达与显著更差的结直肠癌无复发生存期相关，是独立的复发风险因素。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE33113</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 90</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对90例AJCC II期结直肠癌患者进行微阵列分析，患者于1997-2006年间接受了根治性手术，拥有广泛的医疗记录，绝大多数患者可获得长期临床随访数据，用于研究。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE29971</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray (Human Genome U133Plus 2.0)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 96</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 本研究旨在鉴定与两种分子亚型结直肠癌相关的预后基因表达特征，样本来自96例结直肠癌患者的手术切除标本，使用微阵列芯片进行表达谱分析，作为从GSE14333开发的预后基因特征的验证集。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE24550</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Exon Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 167</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对两个独立队列共160例结直肠癌组织样本进行外显子芯片分析，以研究转录组不稳定性，该特征被证明与剪接因子表达水平和患者生存相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE18088</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray (HG-U133 Plus 2.0)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 53</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对53例UICC II期结肠癌患者的肿瘤样本进行基因表达谱分析，旨在验证已发表及自建的预后基因签名，以预测患者术后5年内的无病生存期（DF）与复发（R）结局。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE21510</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 148</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 通过激光显微切割和寡核苷酸微阵列分析104例结直肠癌患者的癌细胞表达谱，以鉴定与远处转移相关的候选基因，并在验证队列中证实OPG过表达与较差的总生存期和无复发生存期显著相关，旨在发现结直肠癌的预后生物标志物和治疗靶点。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE18105</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 111</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 为识别影响结直肠癌患者预后的基因，使用寡核苷酸芯片比较了有或无远处转移的原发肿瘤的基因表达谱，并通过定量PCR在100例患者中验证，发现MUC12低表达与II/III期患者较差的DFS显著相关，证实其是独立的预后因素。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE14333</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Affymetrix Microarray (Human Genome U133Plus 2.0)</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 290</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 从290例结直肠癌患者的手术切除标本中获取肿瘤样本，使用微阵列芯片进行表达谱分析，研究构建了预后分类器，其中训练集包含A期和D期样本，验证集使用了B期和C期样本。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE17537</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 55</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对55例结直肠癌患者进行微阵列分析，基于小鼠模型衍生的转移相关基因表达谱，开发了一个34基因分类器，用于预测结肠癌患者的复发和死亡风险，并在独立数据集中验证了其与复发和死亡风险显著相关，且能独立于常规指标预测复发和死亡。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE17536</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Expression profiling by array</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 177</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用源自高转移性小鼠结肠癌模型的基因表达谱，在177例Moffitt癌症中心的结肠癌患者独立数据集中进行验证，开发了一个34基因分类器用于预测转移和死亡风险，该复发评分在单变量和多变量模型中均能独立预测癌症复发和死亡风险，并在II期和III期患者中显示出与无复发生存期显著相关。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE12032</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 198</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 对129例II期和III期结直肠癌患者的切除标本进行基因表达谱分析，以提取与复发相关的判别基因，并在69例新样本中进行验证，旨在建立用于个体化复发预测和预后判断的基因特征。</span></section></li></ul><p><span leaf=""><br></span></p><p><span leaf=""><span textstyle="">GSE12945</span></span></p><ul><li><section><span leaf="">物种</span><span leaf="">: Homo sapiens</span></section></li><li><section><span leaf="">测序平台</span><span leaf="">: Microarray</span></section></li><li><section><span leaf="">样本量</span><span leaf="">: 62</span></section></li><li><section><span leaf="">实验设计</span><span leaf="">: 使用结直肠癌微阵列数据集验证WIPF1共表达模块，该模块用于对结直肠癌、乳腺癌和胶质瘤患者进行分类，并分析其与生存时间和复发时间的关联，以评估其预后价值。</span></section></li></ul><h2 data-pm-slice="0 0 []"><span leaf=""><br></span></h2><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section data-style="display: inline-block; width: 16px; height: 16px; vertical-align: top; overflow: hidden; background-color: rgba(255, 255, 255, 0); border-width: 1px; border-radius: 26px; border-style: solid; border-color: rgb(152, 186, 189); box-sizing: border-box;"><svg viewbox="0 0 1 1" role="img" aria-label="插图"></svg></section></section></section><section><section powered-by="xiumi.us"><section data-style="display: inline-block; width: 16px; height: 16px; vertical-align: top; overflow: hidden; background-color: rgb(251, 228, 151); border-width: 0px; border-radius: 26px; border-style: none; border-color: rgb(62, 62, 62); box-sizing: border-box;"><svg viewbox="0 0 1 1" role="img" aria-label="插图"></svg></section></section></section><section><section powered-by="xiumi.us"><section data-style="background-color: rgb(152, 186, 189); height: 1px; box-sizing: border-box;"><svg viewbox="0 0 1 1" role="img" aria-label="插图"></svg></section></section></section></section><p powered-by="xiumi.us"><span leaf="">偷偷告诉你，我们在B站还有优质文章分享视频哦~</span></p><p><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8e4saCVV3UImjUtzXGXBXOWvZ7licdDy0icNArmd86pd3RVUXU7Iedsg7zMtOODucZia0FPgT2ovZYiaw/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1#imgIndex=5" alt="图片" data-ratio="1" data-s="300,640" data-type="jpeg" data-w="960" data-imgfileid="100028841" src="https://mmbiz.qpic.cn/mmbiz_jpg/eBfvI7Ryx8e4saCVV3UImjUtzXGXBXOWvZ7licdDy0icNArmd86pd3RVUXU7Iedsg7zMtOODucZia0FPgT2ovZYiaw/640?wx_fmt=other&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1#imgIndex=5"></span></p><p><span leaf=""><br></span></p></section><p><mp-style-type data-value="10000"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/6KxpzqkzM4cU5GokmIjw8Q",target="_blank" rel="noopener noreferrer">原文链接</a>
